Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biweekly Alimta Plus Cisplatin in Advanced Urothelial Cancer
NCT00374868Phase 2Completed
- Sponsor
- Eli Lilly and Company
- Start
- Aug 2006
- Primary completion
- Apr 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of pemetrexed in urothelial carcinoma (UC), sponsored by Eli Lilly and Company. Started Aug 2006; status: completed.
02
Drugs
pemetrexed
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00374868.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00374868.